MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Total Liabilities 2011-2026 | EW
Annual Total Liabilities Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.36 B | 2.99 B | 2.64 B | 2.49 B | 2.67 B | 2.66 B | 2.34 B | 2.18 B | 2.74 B | 1.89 B | 1.56 B | 1.33 B | 1.17 B | 742 M | 643 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.36 B | 643 M | 2.09 B |
Quarterly Total Liabilities Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.07 B | 2.88 B | 2.83 B | 2.99 B | 3.36 B | 2.59 B | 2.55 B | 2.64 B | 2.64 B | 2.56 B | 2.59 B | 2.49 B | 2.42 B | - | 2.58 B | 2.67 B | 2.62 B | - | - | 2.66 B | 2.66 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.36 B | 2.42 B | 2.71 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M |  USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 104.93 | 0.34 % | $ 183 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 167.25 | -5.68 % | $ 12.5 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
389 M | $ 0.4 | 6.74 % | $ 41.1 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 11.08 | -3.82 % | $ 1.66 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 34.41 | -2.65 % | $ 5.13 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 69.2 | -1.38 % | $ 102 B | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.17 | -2.34 % | $ 260 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 35.66 | -2.67 % | $ 1.11 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.33 | -0.51 % | $ 206 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.59 | -1.62 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.21 | -2.64 % | $ 3.45 M | USA |
 |
Establishment Labs Holdings
ESTA
|
334 M | $ 56.38 | -5.9 % | $ 1.67 B |  Costa-rica |
 |
PAVmed
PAVM
|
57.1 M | $ 8.75 | -2.13 % | $ 63.3 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.54 | -0.03 % | $ 122 M | USA |
 |
InspireMD
NSPR
|
14.2 M | $ 1.65 | -4.75 % | $ 106 M | Israel |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.36 | -0.21 % | $ 721 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.3 | -3.08 % | $ 168 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 0.97 | -28.0 % | $ 15.6 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 97.63 | -1.12 % | $ 1.24 B | USA |
 |
Penumbra
PEN
|
399 M | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.74 | -3.73 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 61.48 | -3.41 % | $ 3.35 B |  Britain |
 |
LENSAR
LNSR
|
47.7 M | $ 5.59 | 1.27 % | $ 64.4 M | USA |